Advertisement

Irinotecan and capecitabine combination chemotherapy in a patient with triple-negative breast cancer relapsed after adjuvant chemotherapy with anthracycline and taxane

Abstract

The most effective regimen for taxane- and anthracycline-refractory triple-negative breast cancer (TNBC) has not yet been established. Capecitabine was approved by the US Food and Drug Administration for the treatment of advanced breast cancer and has shown efficacy in advanced breast cancer refractory to anthracyclines and taxanes. Irinotecan has synergism with 5-fluorouracil and shows efficacy in advanced breast cancer. Here we report on a patient with TNBC who relapsed with widespread bone and lung metastases shortly after adjuvant anthracycline followed by taxane chemotherapy. She achieved a metabolic complete response with irinotecan and capecitabine combination therapy and had 10 months’ progression-free survival and 22 months’ overall survival. She relapsed with and died of brain metastasis without any definite signs of progression of the lung and bone lesions she had had before the irinotecan and capecitabine combination therapy. To validate this favorable result, larger clinical trials are warranted in patients with metastatic or relapsed TNBC.

Tumori 2015; 101(1): e9 - e12

Article Type: CASE REPORT

DOI:10.5301/tj.5000198

Authors

Anna Lee, Se-Il Go, Won Sup Lee, Un Seok Lee, Moon Jin Kim, Myoung Hee Kang, Gyeong-Won Lee, Hoon-Gu Kim, Jung Hun Kang, Kyung-Nyeo Jeon, Jae Min Cho, Jeong-Hee Lee

Article History

Disclosures

Financial support: This study was supported in part by a grant of the Korean Cancer Research Institute.
Conflict of interests: None.

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.

Authors

Affiliations

  • Department of Internal Medicine, Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju - Korea
  • Department of Radiology, Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju - Korea
  • Department of Pathology, Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju - Korea
  • These authors contributed equally

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.